Insider · CIK 0001536555
Robert Baltera Jr.
Files at PALI (PALISADE BIO, INC.), FLAC (Frazier Lifesciences Acquisition Corp). First filing Jul 6, 2026, latest Jul 10, 2026.
In brief
Robert Baltera Jr. files SEC Form 4 as director at PALI (PALISADE BIO, INC.), and also at FLAC (Frazier Lifesciences Acquisition Corp). Since Jul 6, 2026, Robert Baltera Jr. has reported 3 open-market buys worth $250k and 0 open-market sells worth $0, the latest filed on Jul 10, 2026.
A track record needs three past buys with six months of prices behind them; Robert Baltera Jr. has 0, so none is measured yet.
The newest scored trade: bought $89k of PALI on Jul 8, 2026, filed Jul 10, 2026, scored 36 (weak). In the last 12 months: 3 buys worth $250k and 0 sells worth $0.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
PALI: PALISADE BIO, INC.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 36Weak | PALIbuy PALISADE BIO, INC. | $89k 45,000 shares | +11% | +280% from low-27% from high | |
| 37Weak | PALIbuy PALISADE BIO, INC. | $102k 50,000 shares | +14% | +278% from low-27% from high | |
| 29Weak | PALIbuy PALISADE BIO, INC. | $59k 30,000 shares | +9% | +265% from low-30% from high |
Transactions
Every row this insider has filed, 8 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jul 8, 2026 | PALI PALISADE BIO, INC. | POpen-market purchase Common Stock | +20,000 | $1.99 | $40k | 436,904 | Jul 10, 2026 |
| Jul 9, 2026 | PALI PALISADE BIO, INC. | POpen-market purchase Common Stock | +25,000 | $1.96 | $49k | 461,904 | Jul 10, 2026 |
| Jul 6, 2026 | PALI PALISADE BIO, INC. | POpen-market purchase Common Stock | +20,000 | $2.05 | $41k | 386,904 | Jul 8, 2026 |
| Jul 7, 2026 | PALI PALISADE BIO, INC. | POpen-market purchase Common Stock | +30,000 | $2.03 | $61k | 416,904 | Jul 8, 2026 |
| Jul 1, 2026 | PALI PALISADE BIO, INC. | POpen-market purchase Common Stock | +20,000 | $1.98 | $40k | 356,904 | Jul 6, 2026 |
| Jul 2, 2026 | PALI PALISADE BIO, INC. | POpen-market purchase Common Stock | +10,000 | $1.98 | $20k | 366,904 | Jul 6, 2026 |
| Jun 10, 2026 | PALI PALISADE BIO, INC. | AGrant or award Common Stock | +336,904 | - | - | 336,904 | Jun 18, 2026 |
| Nov 22, 2022 | FLAC Frazier Lifesciences Acquisition Corp | MOption exercise Class B Ordinary Sharesderivative | -30,000 | - | - | 0 | Nov 23, 2022 |
Questions about Robert Baltera Jr.
Answered from the filings on this page, as of the latest one.
Is Robert Baltera Jr. buying or selling?
In the last 12 months Robert Baltera Jr. reported 3 open-market buys worth $250k and 0 open-market sells worth $0 on SEC Form 4; the latest was bought $89k of PALI on Jul 8, 2026. Grants, option exercises and tax withholding are not counted.
How did Robert Baltera Jr.'s past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Robert Baltera Jr. has 0.
Where does Robert Baltera Jr. file Form 4?
Robert Baltera Jr. has filed Form 4 at PALI (PALISADE BIO, INC.); FLAC (Frazier Lifesciences Acquisition Corp). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.